These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 31225503)
1. Hepatic stress associated with pathologies characterized by disturbed glucose production. Gjorgjieva M; Mithieux G; Rajas F Cell Stress; 2019 Jan; 3(3):86-99. PubMed ID: 31225503 [TBL] [Abstract][Full Text] [Related]
2. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922 [TBL] [Abstract][Full Text] [Related]
3. Glucose-6 Phosphate, A Central Hub for Liver Carbohydrate Metabolism. Rajas F; Gautier-Stein A; Mithieux G Metabolites; 2019 Nov; 9(12):. PubMed ID: 31756997 [No Abstract] [Full Text] [Related]
4. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243 [TBL] [Abstract][Full Text] [Related]
5. Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III. Jauze L; Monteillet L; Mithieux G; Rajas F; Ronzitti G Hum Gene Ther; 2019 Oct; 30(10):1263-1273. PubMed ID: 31319709 [TBL] [Abstract][Full Text] [Related]
6. Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders. Rajas F; Labrune P; Mithieux G Diabetes Metab; 2013 Oct; 39(5):377-87. PubMed ID: 23643353 [TBL] [Abstract][Full Text] [Related]
7. The role of incretin hormones and glucagon in patients with liver disease. Junker AE Dan Med J; 2017 May; 64(5):. PubMed ID: 28552096 [TBL] [Abstract][Full Text] [Related]
8. Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy. Monteillet L; Labrune P; Hochuli M; Do Cao J; Tortereau A; Miliano AC; Ardon-Zitoun C; Duchampt A; Silva M; Verzieux V; Mithieux G; Rajas F Hum Mol Genet; 2022 Mar; 31(6):914-928. PubMed ID: 34617103 [TBL] [Abstract][Full Text] [Related]
9. Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia. Gjorgjieva M; Monteillet L; Calderaro J; Mithieux G; Rajas F J Inherit Metab Dis; 2018 Nov; 41(6):955-963. PubMed ID: 29869165 [TBL] [Abstract][Full Text] [Related]
10. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312 [TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
12. A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD. Ashworth WB; Davies NA; Bogle ID PLoS Comput Biol; 2016 Sep; 12(9):e1005105. PubMed ID: 27632189 [TBL] [Abstract][Full Text] [Related]
13. Cooperation of liver cells in health and disease. Kmieć Z Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749 [TBL] [Abstract][Full Text] [Related]
14. Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition. Huang H; Lee SH; Sousa-Lima I; Kim SS; Hwang WM; Dagon Y; Yang WM; Cho S; Kang MC; Seo JA; Shibata M; Cho H; Belew GD; Bhin J; Desai BN; Ryu MJ; Shong M; Li P; Meng H; Chung BH; Hwang D; Kim MS; Park KS; Macedo MP; White M; Jones J; Kim YB J Clin Invest; 2018 Dec; 128(12):5335-5350. PubMed ID: 30226474 [TBL] [Abstract][Full Text] [Related]
15. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Arguello G; Balboa E; Arrese M; Zanlungo S Biochim Biophys Acta; 2015 Sep; 1852(9):1765-78. PubMed ID: 26027904 [TBL] [Abstract][Full Text] [Related]
16. Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice. Herrema H; Derks TG; van Dijk TH; Bloks VW; Gerding A; Havinga R; Tietge UJ; Müller M; Smit GP; Kuipers F; Reijngoud DJ Hepatology; 2008 Jun; 47(6):1894-904. PubMed ID: 18459129 [TBL] [Abstract][Full Text] [Related]
17. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency. Farah BL; Landau DJ; Sinha RA; Brooks ED; Wu Y; Fung SYS; Tanaka T; Hirayama M; Bay BH; Koeberl DD; Yen PM J Hepatol; 2016 Feb; 64(2):370-379. PubMed ID: 26462884 [TBL] [Abstract][Full Text] [Related]
18. Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies. Zhong J; Gou Y; Zhao P; Dong X; Guo M; Li A; Hao A; Luu HH; He TC; Reid RR; Fan J Pediatr Discov; 2023; 1(2):. PubMed ID: 38370424 [TBL] [Abstract][Full Text] [Related]
19. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855 [TBL] [Abstract][Full Text] [Related]
20. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]